This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Crc Inc., Otsuka Pharmaceutical Company, Limited, Taiho Pharmaceutical Company Limited. Active years: 2010-2015.
Company Filing History:
1 out of 1 
1 out of 846 
1 out of 320 
Years Active: 2010-2015
Title: Seiji Naito: Innovator in Cancer Detection and Treatment
Introduction
Seiji Naito is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of cancer detection and treatment, holding a total of 3 patents. His innovative work focuses on developing methods that enhance the diagnosis and therapeutic strategies for various types of cancer.
Latest Patents
Naito's latest patents include a method for detecting colorectal cancer in its early stages. This involves a tumor marker comprising diacetylspermine, along with a method for evaluating the state of a tumor by reacting an antibody to diacetylspermine with a biological sample. The results from this detection serve as an indicator for assessing the tumor's condition. Additionally, he has developed a method for predicting the therapeutic effect of chemotherapy on renal cell cancer. This invention introduces a novel antitumor agent that combines tegafur, gimeracil, and oteracil potassium, which offers superior therapeutic effects for patients with renal cell carcinoma compared to existing therapies.
Career Highlights
Throughout his career, Seiji Naito has worked with notable organizations, including the Tokyo Metropolitan Government and Otsuka Pharmaceutical Company, Limited. His experience in these institutions has allowed him to refine his expertise in cancer research and treatment.
Collaborations
Naito has collaborated with esteemed colleagues such as Keiichi Takahashi and Taiji Tsukamoto. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Seiji Naito's innovative contributions to cancer detection and treatment exemplify his commitment to improving patient outcomes. His work continues to influence the medical field and offers hope for advancements in cancer therapies.